Stachydrine Suppresses Viability & Migration of Astrocytoma Cells Via CXCR4/ERK & CXCR4/Akt Pathway Activity

Yun Liu(Nanchang University), Songzhi Wei(Nanchang University), Qin Zou(Nanchang University), Yan Luo(Third Affiliated Hospital of Nanchang University)
Future Oncology
June 6, 2018
Cited by 18

Abstract

Aim: Pilocytic astrocytomas (PAs) are a common adolescent malignancy. We evaluated the effects of the betaine stachydrine on human PA cells as well as its associated molecular mechanism(s). Materials & methods: Various experiments assessing stachydrine's effects on the human PA cell line Res186 were performed. Results & conclusion: Stachydrine dose-dependently suppressed proliferation and colony formation in Res186 cells with no such effect on normal astrocytes. Stachydrine downregulated CXCR4 transcription through enhancing IκBα-based NF-κB inhibition. Stachydrine promoted apoptosis and cyclin D1/p27Kip1-associated G0/G1 phase arrest in a CXCR4/ERK- and CXCR4/Akt-dependent manner. Stachydrine suppressed MMP-associated migration and invasiveness via inhibiting CXCR4/Akt/MMP-9/2 and CXCR4/ERK/MMP-9/2 pathway activity. Stachydrine inhibits the viability, migration and invasiveness of human PA cells via inhibiting CXCR4/ERK and CXCR4/Akt signaling.


Related Papers

No related papers found

Powered by citation graph analysis